On Monday, Palisade Bio Inc (NASDAQ: PALI) opened higher 3.95% from the last session, before settling in for the closing price of $1.77. Price fluctuations for PALI have ranged from $1.38 to $22.35 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -38.82% annually for the last half of the decade. Company’s average yearly earnings per share was noted 54.26% at the time writing. With a float of $1.40 million, this company’s outstanding shares have now reached $1.43 million.
In an organization with 9 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 122.4%, operating margin of 5907.2%, and the pretax margin is 5626.0%.
Palisade Bio Inc (PALI) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Palisade Bio Inc is 1.67%, while institutional ownership is 4.36%. The most recent insider transaction that took place on May 28 ’24, was worth 4,863. In this transaction Director of this company bought 1,000 shares at a rate of $4.86, taking the stock ownership to the 1,000 shares. Before that another transaction happened on May 24 ’24, when Company’s CEO, CFO, Director bought 1,000 for $4.81, making the entire transaction worth $4,810. This insider now owns 8,437 shares in total.
Palisade Bio Inc (PALI) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.26% per share during the next fiscal year.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
Check out the current performance indicators for Palisade Bio Inc (PALI). In the past quarter, the stock posted a quick ratio of 3.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -15.04, a number that is poised to hit -2.24 in the next quarter and is forecasted to reach -3.81 in one year’s time.
Technical Analysis of Palisade Bio Inc (PALI)
Let’s dig in a bit further. During the last 5-days, its volume was 14.41 million. That was better than the volume of 0.68 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 31.77%. Additionally, its Average True Range was 0.41.
During the past 100 days, Palisade Bio Inc’s (PALI) raw stochastic average was set at 14.07%, which indicates a significant decrease from 23.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 284.01% in the past 14 days, which was higher than the 129.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.7427, while its 200-day Moving Average is $4.2541. However, in the short run, Palisade Bio Inc’s stock first resistance to watch stands at $2.0233. Second resistance stands at $2.2067. The third major resistance level sits at $2.4233. If the price goes on to break the first support level at $1.6233, it is likely to go to the next support level at $1.4067. The third support level lies at $1.2233 if the price breaches the second support level.
Palisade Bio Inc (NASDAQ: PALI) Key Stats
There are currently 1,329K shares outstanding in the company with a market cap of 1.96 million. Presently, the company’s annual sales total 250 K according to its annual income of -12,300 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -3,490 K.
